نتائج البحث - "Jodie Crawford"

المصدر: Therapeutic Advances in Respiratory Disease, Vol 15 (2021)
Bakerly, N D, Browning, D, Boucot, I, Crawford, J, McCorkindale, S, Stein, N & New, J P 2021, ' The impact of fluticasone furoate/vilanterol on healthcare resource utilisation in the Salford Lung Study in chronic obstructive pulmonary disease ', Therapeutic Advances in Respiratory Disease, vol. 15 . https://doi.org/10.1177/17534666211001013
Therapeutic Advances in Respiratory Disease
Bakerly, N D, Browning, D, Boucot, I, Crawford, J, McCorkindale, S, Stein, N & New, J P 2021, ' The impact of fluticasone furoate/vilanterol on healthcare resource utilisation in the Salford Lung Study in chronic obstructive pulmonary disease ', Therapeutic Advances in Respiratory Disease, vol. 15, pp. 17534666211001013 . https://doi.org/10.1177/17534666211001013

مصطلحات موضوعية: Male, law.invention, chemistry.chemical_compound, Pulmonary Disease, Chronic Obstructive, 0302 clinical medicine, Randomized controlled trial, law, healthcare resource utilisation, Health care, Electronic Health Records, Pharmacology (medical), 030212 general & internal medicine, Prospective Studies, Original Research, Aged, 80 and over, COPD, fluticasone furoate, vilanterol, Health Care Costs, Middle Aged, Hospitalization, Drug Combinations, medicine.anatomical_structure, Female, Vilanterol, medicine.drug, Adult, Pulmonary and Respiratory Medicine, medicine.medical_specialty, Pulmonary disease, effectiveness, Chlorobenzenes, Fluticasone propionate, 03 medical and health sciences, usual care, medicine, Humans, Intensive care medicine, Benzyl Alcohols, Aged, lcsh:RC705-779, Lung, business.industry, lcsh:Diseases of the respiratory system, Length of Stay, Patient Acceptance of Health Care, medicine.disease, Fluticasone furoate/vilanterol, Androstadienes, 030228 respiratory system, chemistry, business

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::385254c675475c1a006c8c614149b8be
https://doaj.org/article/0e25fbfa22b84f6da3da18c66da22f71

Find this article in full text from ProQuest

4

Benefit and safety of fluticasone furoate/vilanterol in the Salford Lung Study in chronic obstructive pulmonary disease (SLS COPD) according to baseline patient characteristics and treatment subgroups

المؤلفون: Susan Collier, Nawar Diar Bakerly, Jørgen Vestbo, John P. New, Ashley Woodcock, Jodie Crawford, Catherine Harvey, David Leather, Isabelle Boucot

المصدر: Bakerly, N D, Woodcock, A, Collier, S, Leather, D A, New, J P, Crawford, J, Harvey, C, Vestbo, J & Boucot, I 2019, ' Benefit and safety of fluticasone furoate/vilanterol in the Salford Lung Study in chronic obstructive pulmonary disease (SLS COPD) according to baseline patient characteristics and treatment subgroups ', Respiratory Medicine, vol. 147, pp. 58-65 . https://doi.org/10.1016/j.rmed.2018.12.016

مصطلحات موضوعية: Male, Lydia Becker Institute, Exacerbation, Salford Lung Study, Effectiveness, law.invention, Pulmonary Disease, Chronic Obstructive, chemistry.chemical_compound, Randomized controlled trial, Adrenal Cortex Hormones, Inhaled corticosteroid, law, Medicine, Prospective Studies, Vilanterol, Lung, education.field_of_study, COPD, Incidence, Chronic obstructive pulmonary disease, Middle Aged, Disease Progression, Female, Safety, medicine.drug, Pulmonary and Respiratory Medicine, medicine.medical_specialty, Population, Muscarinic Antagonists, Chlorobenzenes, Fluticasone propionate, ResearchInstitutes_Networks_Beacons/lydia_becker_institute_of_immunology_and_inflammation, Internal medicine, Administration, Inhalation, Humans, education, Adverse effect, Adrenergic beta-2 Receptor Agonists, Benzyl Alcohols, Aged, Fluticasone furoate, business.industry, Pneumonia, medicine.disease, Fluticasone furoate/vilanterol, Androstadienes, chemistry, business

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8499e2ec66cf05b50aeb568c85c2ad9c
https://doi.org/10.1016/j.rmed.2018.12.016

View record from ScienceDirect

Full Text via ClinicalKey

5

Efficacy and safety of once-daily, single-inhaler fluticasone furoate/umeclidinium/vilanterol versus fluticasone furoate/vilanterol in Japanese patients with inadequately controlled asthma: the CAPTAIN study

المؤلفون: Hironori Sagara, Andrew Fowler, Soichiro Hozawa, Hiroyuki Ohbayashi, Yoichi Nakamura, Laurie A Lee, Takanobu Nishi, Jun Tamaoki, Jodie Crawford

مصطلحات موضوعية: medicine.medical_specialty, Quinuclidines, 030204 cardiovascular system & hematology, Chlorobenzenes, Fluticasone propionate, 03 medical and health sciences, chemistry.chemical_compound, Pulmonary Disease, Chronic Obstructive, 0302 clinical medicine, Double-Blind Method, Japan, Internal medicine, Asthma control, Administration, Inhalation, medicine, Humans, 030212 general & internal medicine, Benzyl Alcohols, Asthma, business.industry, Inhaler, Nebulizers and Vaporizers, General Medicine, medicine.disease, Fluticasone furoate/vilanterol, respiratory tract diseases, Bronchodilator Agents, Androstadienes, Drug Combinations, Treatment Outcome, chemistry, UMECLIDINIUM/VILANTEROL, Vilanterol, Once daily, business, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::87aceaafeba1c5568850a79904d91236

6

Effectiveness of Fluticasone Furoate–Vilanterol for COPD in Clinical Practice

المؤلفون: Jørgen, Vestbo, David, Leather, Nawar, Diar Bakerly, John, New, J Martin, Gibson, Sheila, McCorkindale, Susan, Collier, Jodie, Crawford, Lucy, Frith, Catherine, Harvey, Henrik, Svedsater, Ashley, Woodcock, S, Kwok

المصدر: Vestbo, J, Leather, D, Bakerly, N D, New, J, Gibson, M, Mccorkindale, S, Collier, S, Crawford, J, Frith, L, Harvey, C, Svedsater, H & Woodcock, A 2016, ' Effectiveness of Fluticasone Furoate/Vilanterol in COPD in clinical practice ', The New England Journal of Medicine, vol. 375, pp. 1253-1260 . https://doi.org/10.1056/NEJMoa1608033

وصف الملف: application/vnd.openxmlformats-officedocument.wordprocessingml.document

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c6d57ad876edb7427b64797d0148d765
https://doi.org/10.1056/nejmoa1608033

Find this article in full text from ProQuest

7

Effectiveness versus Efficacy Trials in COPD: How study design influences outcomes and applicability

المؤلفون: Isabelle Boucot, Emma Hilton, Nawar Diar Bakerly, Ashley Woodcock, Jørgen Vestbo, Jodie Crawford, David Leather, Susan Collier

المصدر: Woodcock, A, Boucot, I, Leather, D, Crawford, J, Collier, S, Diar Bakerly, N, Hilton, E & Vestbo, J 2018, ' Effectiveness versus Efficacy Trials in COPD: How study design influences outcomes and applicability. ', European Respiratory Journal . https://doi.org/10.1183/13993003.01531-2017